CPH 0.00% 0.9¢ creso pharma limited

Ann: Halucenex secures Clinical Trial Authorisation, page-3

  1. 1,099 Posts.
    lightbulb Created with Sketch. 652
    It’s disgraceful, absolute BS BOD

    for every million of revenue produced it costs them $6M in cost- wtf is that business model?
    https://hotcopper.com.au/data/attachments/4126/4126415-b788206589871b616c3772c4ea684357.jpg
    Last edited by Tradingasx: 28/02/22
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.